Orchid Pharma Limited (NSE:ORCHPHARMA)
777.10
-15.40 (-1.94%)
Jun 1, 2026, 3:30 PM IST
Orchid Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 832.11 | 211.07 | 36.01 | 225.97 | 43.07 |
Short-Term Investments | - | 0.16 | 0.15 | 40.15 | 0.06 |
Cash & Short-Term Investments | 832.11 | 211.23 | 36.16 | 266.12 | 43.13 |
Cash Growth | 293.94% | 484.23% | -86.41% | 517.08% | -86.32% |
Accounts Receivable | 2,639 | 2,418 | 1,955 | 2,152 | 1,706 |
Other Receivables | 25.8 | 31.38 | 48.07 | 1.58 | 0.01 |
Receivables | 2,665 | 2,450 | 2,004 | 2,154 | 1,706 |
Inventory | 2,564 | 3,264 | 2,642 | 2,287 | 1,727 |
Prepaid Expenses | - | 22.78 | 22.18 | 37.91 | 71.18 |
Other Current Assets | 775.32 | 2,126 | 3,203 | 265.17 | 429.94 |
Total Current Assets | 6,839 | 8,074 | 7,908 | 5,010 | 3,976 |
Property, Plant & Equipment | 9,587 | 6,964 | 6,360 | 6,192 | 5,931 |
Long-Term Investments | 527.11 | 496.86 | 458.4 | 444.41 | 454.98 |
Other Intangible Assets | 736.76 | 170.14 | 149.19 | 3.86 | 3.37 |
Other Long-Term Assets | 1,420 | 1,174 | 663.79 | 601.97 | 739.28 |
Total Assets | 19,109 | 16,879 | 15,539 | 12,252 | 11,106 |
Accounts Payable | 2,299 | 2,221 | 2,296 | 1,744 | 1,677 |
Accrued Expenses | - | 151.8 | 131.62 | 124.31 | 40.03 |
Short-Term Debt | 297.51 | 426.03 | 140.48 | 1,410 | 228.41 |
Current Portion of Long-Term Debt | - | - | - | 415.58 | 369.47 |
Current Portion of Leases | 3.85 | 3.33 | 3.33 | - | - |
Other Current Liabilities | 189.31 | 53.61 | 28.55 | 25.85 | 93.04 |
Total Current Liabilities | 2,790 | 2,856 | 2,600 | 3,719 | 2,408 |
Long-Term Debt | 3,277 | 1,316 | 1,204 | 1,488 | 2,082 |
Long-Term Leases | 47.25 | 0.37 | 3.7 | - | - |
Pension & Post-Retirement Benefits | - | 4.07 | 11.94 | 101.13 | 86.86 |
Long-Term Deferred Tax Liabilities | - | - | - | 32.26 | 32.26 |
Other Long-Term Liabilities | 117.04 | 29.8 | 24.4 | 24.89 | 23.27 |
Total Liabilities | 6,231 | 4,206 | 3,844 | 5,366 | 4,632 |
Common Stock | 507.19 | 507.19 | 507.19 | 408.16 | 408.16 |
Additional Paid-In Capital | - | 8,465 | 8,465 | 4,645 | 4,645 |
Retained Earnings | - | -15,190 | -16,180 | -17,097 | -17,558 |
Comprehensive Income & Other | 12,371 | 18,891 | 18,902 | 18,931 | 18,979 |
Shareholders' Equity | 12,878 | 12,673 | 11,695 | 6,886 | 6,474 |
Total Liabilities & Equity | 19,109 | 16,879 | 15,539 | 12,252 | 11,106 |
Total Debt | 3,626 | 1,746 | 1,352 | 3,313 | 2,680 |
Net Cash (Debt) | -2,794 | -1,535 | -1,316 | -3,047 | -2,636 |
Net Cash Per Share | -55.07 | -30.26 | -27.20 | -74.66 | -64.59 |
Filing Date Shares Outstanding | 50.7 | 50.72 | 50.72 | 40.82 | 40.82 |
Total Common Shares Outstanding | 50.7 | 50.72 | 50.72 | 40.82 | 40.82 |
Working Capital | 4,049 | 5,218 | 5,308 | 1,291 | 1,569 |
Book Value Per Share | 253.98 | 249.86 | 230.58 | 168.72 | 158.61 |
Tangible Book Value | 12,141 | 12,503 | 11,545 | 6,883 | 6,470 |
Tangible Book Value Per Share | 239.45 | 246.51 | 227.64 | 168.62 | 158.53 |
Land | - | 408.16 | 256.47 | 218.47 | 122.87 |
Buildings | - | 1,865 | 1,849 | 1,783 | 1,439 |
Machinery | - | 11,071 | 10,773 | 10,097 | 10,095 |
Construction In Progress | - | 644.89 | 163.94 | 464.63 | 97.84 |